Condition
Malignant Pleural Mesothelioma
Estimated Enrollment: 6
Age Group: 18 Years to 75 Years (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: No masking|Primary Purpose: Treatment
Study ID Numbers: 2014_01|2015-001554-15
Study First Received: January 14, 2016
Last Updated: February 1, 2017
Estimated Primary Completion Date: November 2017
Primary Outcome Measures:
Number of Patients having the full multimodal treatment without unacceptable and unexpected toxicities (grade ≥ 3) graded According to NCI CTC Version 4.0|Number of responders or stable patients after surgery|Progression-free survival (PFS)|Quality of life assessed by a specific questionnaire MPM (HCCA EORTC-30)
Sponsors and Collaborators:
University Hospital, Lille|Institut National de la Santé Et de la Recherche Médicale, France|University of Pennsylvania|Région Nord-Pas de Calais, France
Website Link: https://ClinicalTrials.gov/show/NCT02662504
